血栓形成
医学
传统PCI
经皮冠状动脉介入治疗
内科学
心脏病学
血栓
抗血栓
临床终点
冠状动脉疾病
入射(几何)
外科
随机对照试验
血栓形成
心肌梗塞
物理
光学
作者
Nobuhiro Nakanishi,Koichi Kaikita,Masanobu Ishii,Naoto Kuyama,Noriaki Tabata,Miwa Ito,Kenshi Yamanaga,Koichiro Fujisue,Tadashi Hoshiyama,Hisanori Kanazawa,Shinsuke Hanatani,Daisuke Sueta,Seiji Takashio,Yuichiro Arima,Satoshi Araki,Hiroki Usuku,Taishi Nakamura,Satoru Suzuki,Eiichiro Yamamoto,Hirofumi Soejima
标识
DOI:10.1016/j.numecd.2022.01.016
摘要
Although antithrombotic treatments are established for coronary artery disease (CAD), they increase the bleeding risk, especially in malnourished patients. The total thrombus-formation analysis system (T-TAS) is useful for the assessment of thrombogenicity in CAD patients. Here, we examined the relationships among malnutrition, thrombogenicity and 1-year bleeding events in patients undergoing percutaneous coronary intervention (PCI).This was a retrospective analysis of 300 consecutive CAD patients undergoing PCI. Blood samples obtained on the day of PCI were used in the T-TAS to compute the thrombus formation area under the curve. We assigned patients to two groups based on the geriatric nutritional risk index (GNRI): 102 patients to the lower GNRI group (≤98), 198 patients to the higher GNRI group (98<). The primary endpoint was the incidence of 1-year bleeding events defined by Bleeding Academic Research Consortium criteria types 2, 3, or 5. The T-TAS levels were lower in the lower GNRI group than in the higher GNRI group. Kaplan-Meier analysis showed worse 1-year bleeding event-free survival in the lower GNRI group compared with the higher GNRI group. The combined model of the GNRI and the Academic Research Consortium for High Bleeding Risk (ARC-HBR) had good calibration and discrimination for bleeding risk prediction. In addition, having a lower GNRI and ARC-HBR positivity was associated with 1-year bleeding events.A lower GNRI could reflect low thrombogenicity evaluated by the T-TAS and determine bleeding risk in combination with ARC-HBR positivity.
科研通智能强力驱动
Strongly Powered by AbleSci AI